TURK İLAÇ VE SERUM SANAYİ A.Ş. Logo

TURK İLAÇ VE SERUM SANAYİ A.Ş.

Turkish producer of pharmaceuticals, specializing in IV solutions and vaccines for hospitals.

TRILC | IS

Overview

Corporate Details

ISIN(s):
TRETRLC00014 (+1 more)
LEI:
78900003BNEUMO8X3Y93
Country:
Türkiye
Address:
BÜĞDÜZ MAH. ENVER PAŞA CAD. NO: 8 AKYURT / ANKARA, 06750 ANKARA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Turk İlaç ve Serum Sanayi A.Ş. is a pharmaceutical company specializing in the production of human medicines. The company operates Turkey's highest-capacity IV parenteral solution (serum) production facility and is a major supplier to the country's public and private hospitals. A pioneer in domestic vaccine manufacturing, it established Turkey's first private vaccine production plant. Its portfolio also includes a range of other pharmaceuticals such as tablets, capsules, ampoules, and vials, all produced in its integrated, GMP-compliant facilities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-07 13:01
Regulatory News Service
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-10-07 12:49
Regulatory News Service
DMO İhale Sonucu Hakkında
English 42.6 KB
2025-09-29 14:13
Capital/Financing Update
Finansman Bonosu İtfası Hakkında
English 15.2 KB
2025-09-29 07:01
Capital/Financing Update
Satışın Tamamlanması Hakkında
English 18.2 KB
2025-09-25 14:55
Capital/Financing Update
Borçlanma Aracı İhracı Hakkında
English 17.9 KB
2025-09-22 22:36
Capital/Financing Update
Borçlanma Aracı İhraç Belgesi
Turkish 4.6 MB
2025-09-22 22:36
Capital/Financing Update
Borçlanma Aracı İhraç Belgesi
Turkish 15.2 KB
2025-09-19 21:38
Regulatory News Service
Borçlanma Aracı İhraç Tavanının SPK Tarafından Onaylanması
Turkish 5.4 KB
2025-09-03 17:47
Capital/Financing Update
Borçlanma Aracı İhracına İlişkin Yönetim Kurulu Kararı Alınması
Turkish 4.9 KB
2025-08-20 08:58
Regulatory News Service
Türkmenİstan Sağlık ve İlaç Bakanlığı ile imzalanan Sözleşmenin Sevkiyatlarının…
Turkish 17.8 KB
2025-08-18 20:29
Interim Report
Participation Finance Principles Information Form
English 52.6 KB
2025-08-13 09:08
Regulatory News Service
DMO İhale Sonucu Hakkında
English 42.1 KB
2025-08-11 18:29
Interim Report
Sorumluluk Beyanı
Turkish 20.4 KB
2025-08-11 18:29
Interim Report
Financial Report
Turkish 2.0 MB
2025-08-11 18:29
Annual / Quarterly Financial Statement
Financial Report
English 2.5 MB

Automate Your Workflow. Get a real-time feed of all TURK İLAÇ VE SERUM SANAYİ A.Ş. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TURK İLAÇ VE SERUM SANAYİ A.Ş.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TURK İLAÇ VE SERUM SANAYİ A.Ş. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.